Andrés Sebastián Cadena Paredes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrés Sebastián Cadena Paredes has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ana Karina Zambrano
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications - Elius Paz-Cruz
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications - Patricia Guevara-Ramírez
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications - Rafael Tamayo-Trujillo
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications - Santiago Cadena-Ullauri
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications - Viviana A. Ruiz-Pozo
Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador
2 shared publications
Latest Publications
- 11 November 2026
- Published by Medwave Estudios Limitada in Medwave
- Vol. 26 (10) , e3232
Genetics of addiction to substances of abuse: reward system, neuroplasticity and genetic susceptibility
Introduction Substance abuse is a public health problem resulting from the interaction between exposure, neuroadaptations, and genetic susceptibility. This review aimed to synthesize recent evidence on the genes and neurobiological systems involved in the development of substance abuse. Methods A literature review was conducted, primarily of articles published within the last 10 years. MEDLINE/PubMed, Scopus, Web of Science, ScienceDirect, and specialized genetic and biomedical information resources were consulted, yielding 158 references on the genetics of addiction, neurotransmission, neuroplasticity, and the use of alcohol, nicotine, cannabis, cocaine, and opioids were included. Results Addiction arises from the interaction between repeated exposure to substances of abuse, persistent neuroadaptations, and genetic susceptibility. The main neurobiological alterations involve the ventral tegmental area, nucleus accumbens, prefrontal cortex, amygdala, and hippocampus, with participation from the dopaminergic, glutamatergic, GABAergic, opioid, endocannabinoid, cholinergic, serotonergic, and noradrenergic systems. Genetic variants in and have been associated with susceptibility to developing substance use disorders. Furthermore, chronic exposure alters pathways such as cAMP/PKA, CREB, FosB, AP-1, and ERK, which promotes tolerance, dependence, sensitization, and relapse. However, most of the described variants contribute only to a limited extent to susceptibility to substance abuse, and their magnitude may differ depending on the substance, methodological differences between studies, and the type of population studied. Conclusions Susceptibility to addiction may arise from a complex interaction between genetic, neurobiological, and potentially environmental factors. However, larger functional, population-based, and multi-ethnic studies are needed to validate these associations and determine their usefulness in prevention, risk stratification, and personalized therapies.
- 11 November 2026
- Published by Medwave Estudios Limitada in Medwave
- Vol. 26 (10) , e3232
Genetics of addiction to substances of abuse: reward system, neuroplasticity and genetic susceptibility
Introduction Substance abuse is a public health problem resulting from the interaction between exposure, neuroadaptations, and genetic susceptibility. This review aimed to synthesize recent evidence on the genes and neurobiological systems involved in the development of substance abuse. Methods A literature review was conducted, primarily of articles published within the last 10 years. MEDLINE/PubMed, Scopus, Web of Science, ScienceDirect, and specialized genetic and biomedical information resources were consulted, yielding 158 references on the genetics of addiction, neurotransmission, neuroplasticity, and the use of alcohol, nicotine, cannabis, cocaine, and opioids were included. Results Addiction arises from the interaction between repeated exposure to substances of abuse, persistent neuroadaptations, and genetic susceptibility. The main neurobiological alterations involve the ventral tegmental area, nucleus accumbens, prefrontal cortex, amygdala, and hippocampus, with participation from the dopaminergic, glutamatergic, GABAergic, opioid, endocannabinoid, cholinergic, serotonergic, and noradrenergic systems. Genetic variants in and have been associated with susceptibility to developing substance use disorders. Furthermore, chronic exposure alters pathways such as cAMP/PKA, CREB, FosB, AP-1, and ERK, which promotes tolerance, dependence, sensitization, and relapse. However, most of the described variants contribute only to a limited extent to susceptibility to substance abuse, and their magnitude may differ depending on the substance, methodological differences between studies, and the type of population studied. Conclusions Susceptibility to addiction may arise from a complex interaction between genetic, neurobiological, and potentially environmental factors. However, larger functional, population-based, and multi-ethnic studies are needed to validate these associations and determine their usefulness in prevention, risk stratification, and personalized therapies.
- Open Access
- 17 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1565
Atopic Dermatitis Beyond Cutaneous Inflammation: The Interplay Between Progesterone, Testosterone, Gut Microbiota, and Immune Dysregulation
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by epithelial barrier dysfunction, immune dysregulation, and marked clinical heterogeneity. Although sex hormones and gut microbiota have independently been implicated in AD, their potential interactions remain incompletely understood. This narrative review integrates evidence from clinical, experimental, and preclinical studies examining the interplay among progesterone, testosterone, gut microbiota, and AD, with emphasis on immune regulation, epithelial barrier function, and gut–skin communication. Overall, the available evidence suggests that progesterone is predominantly associated with type 2 immune responses, alterations in epithelial barrier homeostasis, and context-dependent microbial remodeling. In contrast, physiological testosterone is generally associated with immunoregulatory effects and microbial profiles enriched in short-chain fatty acid-producing bacteria, whereas local androgen metabolism may contribute to skin barrier dysfunction. Current evidence also supports a bidirectional relationship between gut microbiota and sex hormones, whereby hormonal fluctuations influence microbial composition while microbial metabolism may modify steroid hormone bioavailability. Collectively, these findings support an integrated endocrine–microbial–immune framework that may contribute to AD beyond cutaneous inflammation. Although direct evidence simultaneously evaluating these components remains limited, this framework may help explain sex-specific differences in disease susceptibility, severity, and clinical course while guiding future mechanistic studies of the hormone–gut microbiota–skin axis.
- 17 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1565
Open AccessAtopic Dermatitis Beyond Cutaneous Inflammation: The Interplay Between Progesterone, Testosterone, Gut Microbiota, and Immune Dysregulation
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by epithelial barrier dysfunction, immune dysregulation, and marked clinical heterogeneity. Although sex hormones and gut microbiota have independently been implicated in AD, their potential interactions remain incompletely understood. This narrative review integrates evidence from clinical, experimental, and preclinical studies examining the interplay among progesterone, testosterone, gut microbiota, and AD, with emphasis on immune regulation, epithelial barrier function, and gut–skin communication. Overall, the available evidence suggests that progesterone is predominantly associated with type 2 immune responses, alterations in epithelial barrier homeostasis, and context-dependent microbial remodeling. In contrast, physiological testosterone is generally associated with immunoregulatory effects and microbial profiles enriched in short-chain fatty acid-producing bacteria, whereas local androgen metabolism may contribute to skin barrier dysfunction. Current evidence also supports a bidirectional relationship between gut microbiota and sex hormones, whereby hormonal fluctuations influence microbial composition while microbial metabolism may modify steroid hormone bioavailability. Collectively, these findings support an integrated endocrine–microbial–immune framework that may contribute to AD beyond cutaneous inflammation. Although direct evidence simultaneously evaluating these components remains limited, this framework may help explain sex-specific differences in disease susceptibility, severity, and clinical course while guiding future mechanistic studies of the hormone–gut microbiota–skin axis.
- Open Access
- 1 December 2020
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 14 (4) , 2339-2349
Quantification of FEND and ITUDI Anti-fungal Lipopeptide Gene Expression in Bacillus megaterium using RT-qPCR
- 1 December 2020
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 14 (4) , 2339-2349
Open AccessQuantification of FEND and ITUDI Anti-fungal Lipopeptide Gene Expression in Bacillus megaterium using RT-qPCR